Grandview Asset Management LLC Abb Vie Inc. Transaction History

Grandview Asset Management LLC

$171 Million
Q2 2024

A detailed history of Grandview Asset Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Grandview Asset Management LLC holds 18,215 shares of ABBV stock, worth $3.52 Million. This represents 1.83% of its overall portfolio holdings.

Number of Shares

18,215

Previous 18,550 1.81%

Holding current value

$3.52 Million

Previous $3.38 Million 7.52%

% of portfolio

1.83%

Previous 1.53%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	SELL	$154.79 - $180.76 $51,854 - $60,554	-335 Reduced 1.81%	18,215 $3.12 Million
Q1 2024 Apr 10, 2024	SELL	$159.82 - $182.1 $47,946 - $54,630	-300 Reduced 1.59%	18,550 $3.38 Million
Q4 2023 Jan 11, 2024	SELL	$137.6 - $154.97 $105,814 - $119,171	-769 Reduced 3.92%	18,850 $2.92 Million
Q3 2023 Oct 27, 2023	SELL	$133.59 - $154.65 $198,915 - $230,273	-1,489 Reduced 7.05%	19,619 $2.92 Million
Q2 2023 Jul 07, 2023	SELL	$132.51 - $164.9 $246,998 - $307,373	-1,864 Reduced 8.11%	21,108 $2.84 Million
Q1 2023 Apr 13, 2023	SELL	$144.61 - $166.54 $333,181 - $383,708	-2,304 Reduced 9.12%	22,972 $3.66 Million
Q4 2022 Jan 09, 2023	SELL	$138.31 - $165.87 $162,237 - $194,565	-1,173 Reduced 4.43%	25,276 $4.09 Million
Q3 2022 Oct 11, 2022	SELL	$134.21 - $153.93 $158,502 - $181,791	-1,181 Reduced 4.27%	26,449 $3.55 Million
Q2 2022 Jul 11, 2022	SELL	$137.62 - $174.96 $118,766 - $150,990	-863 Reduced 3.03%	27,630 $4.23 Million
Q1 2022 Apr 26, 2022	SELL	$131.98 - $163.75 $71,401 - $88,588	-541 Reduced 1.86%	28,493 $4.62 Million
Q4 2021 Jan 21, 2022	BUY	$107.43 - $135.93 $57,582 - $72,858	536 Added 1.88%	29,034 $3.93 Million
Q3 2021 Nov 10, 2021	SELL	$106.4 - $120.78 $20,428 - $23,189	-192 Reduced 0.67%	28,498 $3.07 Million
Q2 2021 Jul 21, 2021	BUY	$105.21 - $117.21 $284,382 - $316,818	2,703 Added 10.4%	28,690 $3.23 Million
Q1 2021 May 06, 2021	BUY	$102.3 - $112.62 $2.64 Million - $2.9 Million	25,787 Added 12893.5%	25,987 $2.81 Million
Q1 2021 May 06, 2021	SELL	$102.3 - $112.62 $2.66 Million - $2.93 Million	-25,993 Reduced 99.24%	200 $42,000
Q4 2020 Jan 21, 2021	BUY	$80.49 - $108.67 $31,793 - $42,924	395 Added 1.53%	26,193 $2.81 Million
Q3 2020 Oct 30, 2020	SELL	$85.91 - $100.83 $111,339 - $130,675	-1,296 Reduced 4.78%	25,798 $2.26 Million
Q2 2020 Jul 23, 2020	BUY	$73.37 - $98.18 $1.99 Million - $2.66 Million	27,094 New	27,094 $2.66 Million

Others Institutions Holding ABBV

# of Institutions

3,689

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $342B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grandview Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grandview Asset Management LLC with notifications on news.

Account

Grandview Asset Management LLC Abb Vie Inc. Transaction History